Oral etoposide in the treatment of malignant mesothelioma. A phase II study.
Tammilehto
L
L
Department of Epidemiology and Biostatistics, Institute of Occupational Health, Helsinki, Finland.
Maasilta
P
P
Mäntylä
M
M
Salo
J
J
Mattson
K
K
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy*; D008875:Middle Aged; D010534:Peritoneal Neoplasms / Q000188:drug therapy; D010997:Pleural Neoplasms / Q000188:drug therapy; D012074:Remission Induction
D005047:Etoposide